JP2002249428A5 - - Google Patents

Download PDF

Info

Publication number
JP2002249428A5
JP2002249428A5 JP2001336106A JP2001336106A JP2002249428A5 JP 2002249428 A5 JP2002249428 A5 JP 2002249428A5 JP 2001336106 A JP2001336106 A JP 2001336106A JP 2001336106 A JP2001336106 A JP 2001336106A JP 2002249428 A5 JP2002249428 A5 JP 2002249428A5
Authority
JP
Japan
Prior art keywords
pravastatin
pantethine
taurine
content
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001336106A
Other languages
English (en)
Other versions
JP4248780B2 (ja
JP2002249428A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2001336106A priority Critical patent/JP4248780B2/ja
Priority claimed from JP2001336106A external-priority patent/JP4248780B2/ja
Publication of JP2002249428A publication Critical patent/JP2002249428A/ja
Publication of JP2002249428A5 publication Critical patent/JP2002249428A5/ja
Application granted granted Critical
Publication of JP4248780B2 publication Critical patent/JP4248780B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Claims (6)

  1. プラバスタチンと、タウリン、パンテチン及びイノシトールヘキサニコチネートからなる群から選択される1種以上の物質とを含有する、血中過酸化脂質低下剤組成物。
  2. 請求項1の組成物において、プラバスタチンの重量%が0.01乃至5重量%であり、タウリンの重量%が0.3乃至50重量%であり、パンテチンの重量%が1.3乃至50重量%であり、イノシトールヘキサニコチネートの重量%が0.05乃至50重量%である固形製剤。
  3. 請求項1の組成物において、プラバスタチンの含有量が1乃至100mg/mLであり、タウリンの含有量が2.5乃至50mg/mLであり、パンテチンの含有量が1乃至200mg/mLであり、イノシトールヘキサニコチネートの含有量が1乃至40mg/mLである液剤。
  4. プラバスタチンとタウリンとを含有する、請求項2又は請求項3に記載された組成物。
  5. プラバスタチンとパンテチンとを含有する、請求項2又は請求項3に記載された組成物。
  6. プラバスタチンとイノシトールヘキサニコチネートとを含有する、請求項2又は請求項3に記載された組成物。
JP2001336106A 2000-11-07 2001-11-01 過酸化脂質低下剤組成物 Expired - Fee Related JP4248780B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001336106A JP4248780B2 (ja) 2000-11-07 2001-11-01 過酸化脂質低下剤組成物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000-339457 2000-11-07
JP2000339457 2000-11-07
JP2000-383053 2000-12-18
JP2000383053 2000-12-18
JP2001336106A JP4248780B2 (ja) 2000-11-07 2001-11-01 過酸化脂質低下剤組成物

Publications (3)

Publication Number Publication Date
JP2002249428A JP2002249428A (ja) 2002-09-06
JP2002249428A5 true JP2002249428A5 (ja) 2005-06-30
JP4248780B2 JP4248780B2 (ja) 2009-04-02

Family

ID=27345134

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001336106A Expired - Fee Related JP4248780B2 (ja) 2000-11-07 2001-11-01 過酸化脂質低下剤組成物

Country Status (1)

Country Link
JP (1) JP4248780B2 (ja)

Similar Documents

Publication Publication Date Title
JP2003520232A5 (ja)
CA2407100A1 (en) 1-aroyl-piperidinyl benzamidines
TNSN06439A1 (fr) Derives de 2-carbamide -4-phenylthiazole, leur preparation et leur application en therapeutique
TNSN07145A1 (fr) Derives de 2-amido-4-phenylthiazole, leur preparation et leur application en therapeutique
BR0013157A (pt) Composições farmacêuticas e nutricionais contendo ácidos graxos essenciais e agentes de abaixamento da homocisteìna
ITRM990338A0 (it) Composizione dietetica o farmaceutica utile per la prevenzione o il trattamento dell'iperossaluria.
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
SE0001899D0 (sv) New compounds
TR201820868T4 (tr) Sindirilemeyen oligosakkritler içeren besin bileşimi.
NO20042596L (no) Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1
BR0107157A (pt) Diagnose e tratamento de condições cardiovasculares
PT1294402E (pt) Compostos com um grupo sulfonamida e composicoes farmaceuticas contendo estes compostos
CA2367387A1 (en) Composition comprising isoquercetin and ascorbic acid in a sustained release form
KR940005282A (ko) 안토시아노사이드를 함유하는 경구용 약제학적 조성물
WO2002042271A3 (en) Biphenylcarboxamides useful as lipid lowering agents
JP2005527551A5 (ja)
NZ516290A (en) Substituted phenoxyacetic acids
CA2305933A1 (fr) Composes (poly)thia-alcynoiques et leurs derives, compositions les comprenant et leur utilisation
MXPA05011895A (es) Composiciones para lipidos inferiores en el cuerpo.
WO2001081328A3 (en) Thiazolidinedione analogues and their use for the treatment of diabetes
CA2442210A1 (en) Aryl oxime-piperazines useful as ccr5 antagonists
JP2002249428A5 (ja)
WO2004050123A3 (en) Concentrated liquid valdecoxib composition
BR0314451A (pt) Composição lìquida de limpeza pessoal
TR199800301A2 (xx) S�lfonamid-substit�e edilmi� 7 halkal� bile�ikler.